Aller au contenu
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Langue
Tous les champs
Titre
Auteur
Sujet
Cote
ISBN/ISSN
Tag
Rechercher
Recherche avancée
VEGF-A and FLT-1 tumour gene e...
Citer
Envoyer par SMS
Envoyer par courriel
Imprimer
Exporter les notices
Exporter vers RefWorks
Exporter vers EndNoteWeb
Exporter vers EndNote
Permalien
VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy
Détails bibliographiques
Auteurs principaux:
Brueckl, WM
,
Wirtz, R
,
Dimmler, A
,
Brunner, T
,
Klein, P
,
Hahn, E
,
Ficker, J
,
Wiest, G
Format:
Journal article
Publié:
2009
Exemplaires
Description
Documents similaires
Affichage MARC
Description
Résumé:
Documents similaires
TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
par: Papadopoulos Thomas, et autres
Publié: (2007-08-01)
Development and Validation of a Simplified Prognostic Score in SCLC
par: Elodie Negre, MD, et autres
Publié: (2020-03-01)
Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
par: Jin Yujuan, et autres
Publié: (2023-05-01)
Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
par: Jiaping Liu, et autres
Publié: (2024-06-01)
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
par: Kana Hashimoto, MD, et autres
Publié: (2024-11-01)